What is Veracyte's contract liabilities?

Veracyte (VCYT) reported contract liabilities of $0 in Q4 2022.

How has Veracyte's contract liabilities changed year-over-year?

Veracyte's contract liabilities decreased by 100.0% year-over-year, from $343K to $0.

What is the long-term trend for Veracyte's contract liabilities?

Over 2 years (2020 to 2022), Veracyte's contract liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $829K to $0.

What does contract liabilities mean?

Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.

Veracyte VCYT Contract Liabilities

Discontinued — last reported Q4 '22

Contract Liabilities at other companies

Natera, Inc.NTRA

$17M—

Idexx LaboratoriesIDXX

$32.31M+20.5%

Adaptive BiotechnologiesADPT

$807K-96.7%

Guardant HealthGH

——

Agilent TechnologiesA

——

DanaherDHR

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Veracyte’s 10-K, filed March 1, 2023, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's contract liabilities?: Veracyte (VCYT) reported contract liabilities of $0 in Q4 2022.
How has Veracyte's contract liabilities changed year-over-year?: Veracyte's contract liabilities decreased by 100.0% year-over-year, from $343K to $0.
What is the long-term trend for Veracyte's contract liabilities?: Over 2 years (2020 to 2022), Veracyte's contract liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $829K to $0.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.